You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TPN171H

Showing 1 - 25 of 2,498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects Trial in Shanghai (TPN171H 10 mg Group, TPN171H 30 mg Group, TPN171H 40 mg Group)

Recruiting
  • Healthy Subjects
  • TPN171H 10 mg Group
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital affiliated to Fudan University
Feb 19, 2023

Erectile Dysfunction Trial in Shanghai (TPN171H)

Completed
  • Erectile Dysfunction
  • TPN171H
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 17, 2023

Erectile Dysfunction Trial in Shanghai (TPN171H, Itraconazole, Rifampicin)

Completed
  • Erectile Dysfunction
  • TPN171H
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 17, 2023

Erectile Dysfunction Trial in Beijing (TPN171H 10mg, TPN171H Placebo)

Recruiting
  • Erectile Dysfunction
  • TPN171H 10mg
  • TPN171H Placebo
  • Beijing, Beijing, China
    Peking University First Hospital
Dec 4, 2022

Pulmonary Arterial Hypertension Trial in Shanghai (TPN171H)

Completed
  • Pulmonary Arterial Hypertension
  • TPN171H
  • Shanghai, China
    Fu Zhu
Jul 6, 2023

Erectile Dysfunction Trial in China (TPN171H 2.5mg, TPN171H 5mg, TPN171H 10mg)

Recruiting
  • Erectile Dysfunction
  • TPN171H 2.5mg
  • +4 more
  • Hefei, Anhui, China
  • +7 more
Jan 30, 2023

Alcohol, Phosphodiesterase Inhibitor, Erectile Dysfunction Trial in Shanghai (TPN171H tablet plus alcohol, alcohol, TPN171H

Completed
  • Alcohol
  • +2 more
  • TPN171H tablet plus alcohol
  • +2 more
  • Shanghai, China
    Shanghai Xuhui Central Hospital
May 20, 2022

Pulmonary Arterial Hypertension, Erectile Dysfunction Trial in Chengdu (TPN171H single dose)

Recruiting
  • Pulmonary Arterial Hypertension
  • Erectile Dysfunction
  • TPN171H single dose
  • Chengdu, Sichuan, China
  • +1 more
May 16, 2022

Erectile Dysfunction, Pulmonary Arterial Hypertension Trial in Changchun (TPN171H)

Completed
  • Erectile Dysfunction
  • Pulmonary Arterial Hypertension
  • TPN171H
  • Changchun, China
    The First Affiliated Hospital of Jilin University
Mar 22, 2022

Pulmonary Arterial Hypertension Trial in China (TPN171H, Placebo, Tadalafil)

Completed
  • Pulmonary Arterial Hypertension
  • TPN171H
  • +2 more
  • Beijing, Beijing, China
  • +8 more
Jun 30, 2022

Erectile Dysfunction Trial in China (TPN171H, )

Completed
  • Erectile Dysfunction
  • TPN171H
  • placebo
  • Hefei, Anhui, China
  • +11 more
Dec 30, 2021

Healthy Male Subjects Trial in Shanghai ([14C]TPN171H)

Completed
  • Healthy Male Subjects
  • Shanghai, China
    Shanghai Xuhui Central Hospital
Feb 24, 2021

Erectile Dysfunction Trial in China (TPN171H 2.5mg group, TPN171H 5mg group, TPN171H 10mg group)

Recruiting
  • Erectile Dysfunction
  • TPN171H 2.5mg group
  • +3 more
  • Hefei, Anhui, China
  • +46 more
Jan 20, 2022

Multiple Myeloma Trial in Montréal (ECT-001 (UM171) expanded cord blood)

Active, not recruiting
  • Multiple Myeloma
  • ECT-001 (UM171) expanded cord blood
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maiso
Mar 8, 2022

Familial Chylomicronemia Syndrome Trial in Canada, Sweden, United States (Olezarsen)

Recruiting
  • Familial Chylomicronemia Syndrome
  • Huntington Beach, California
  • +10 more
Aug 4, 2022

High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)

Recruiting
  • High Risk Hematologic Malignancy
  • Cord Blood Transplant
  • Transplant with an expanded ECT-001 cord blood
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
Aug 2, 2021

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

Recruiting
  • High Risk Myeloid Malignancies
  • Cord Blood Transplant
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2022

Heart Failure, Atrial Fibrillation Trial in Worldwide (Rhythm control, Rate Control)

Completed
  • Heart Failure
  • Atrial Fibrillation
  • Rhythm control
  • Rate Control
  • Porto Alegre, Rio Grande Do Sul, Brazil
  • +20 more
Oct 13, 2021

Respiratory Syncytial Virus Infection Prevention Trial in Worldwide (Ad26.RSV.preF-based Vaccine, Placebo)

Completed
  • Respiratory Syncytial Virus Infection Prevention
  • Ad26.RSV.preF-based Vaccine
  • Placebo
  • Coral Gables, Florida
  • +22 more
Sep 27, 2022

Advanced Melanoma Trial in Worldwide (lenvatinib, pembrolizumab)

Active, not recruiting
  • Advanced Melanoma
  • Chandler, Arizona
  • +22 more
Jul 21, 2022

Prostatic Tumors Trial in Worldwide (Prostatectomy/Surgery, Radiotherapy with adjuvant androgen deprivation therapy)

Recruiting
  • Prostatic Neoplasms
  • Prostatectomy/Surgery
  • Radiotherapy with adjuvant androgen deprivation therapy
  • Aalborg, Denmark
  • +29 more
Mar 30, 2022

Merkel Cell Carcinoma Trial in Worldwide (Pembrolizumab (MK-3475))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab (MK-3475)
  • New York, New York
  • +21 more
Nov 30, 2022

Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia Associated Pulmonary Hypertension, Pulmonary Hypertension Trial in

Completed
Has Results
  • Bronchopulmonary Dysplasia
  • +4 more
  • Enteral L-citrulline
  • Galveston, Texas
    University of Texas Medical Branch
Sep 27, 2021